Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), FACP, FIDSA, FECMM, FAAM Texas 4000 Distinguished Endowed Professor For Cancer Research Deputy Head, Division of Internal Medicine The University of Texas MD Anderson Cancer Center Houston, TX Dimitrios P. Kontoyiannis, MD, ScD, PhD (Hon), is the Texas 4000 Distinguished Professor for Cancer Research and Deputy Head-Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center. He is also an adjunct professor at Baylor College of Medicine and University of Houston College of Pharmacy in Houston Texas. He received his medical degree Summa Cum Laude from the National and Kapodistrian University of Athens in Greece. Dr. Kontoyiannis also completed a post-doctoral clinical research fellowship at the Section of Infectious Diseases at The University of Texas MD Anderson Cancer Center in Houston, TX, followed by training in Internal Medicine at Baylor College of Medicine in Houston, TX, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a Master in Clinical Sciences from Harvard Medical School in Boston. He spent 3 years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program. Dr. Kontoyiannis has authored more than 500 peer-reviewed manuscripts and been invited to give over 300 lectures in international conferences and prestigious institutions in US and abroad. He serves as an associate editor for Mycoses and J of Infection and sits in the editorial Boards of many journals, including Antimicrobial Agents & Chemotherapy, JID. Transplantation Infectious Diseases. He is a reviewer for several other peer-reviewed journals in Infectious Diseases, Oncology and Hematology. An international expert in clinical and experimental mycology, and is considered the leading expert in mycology worldwide (expertscape.com) and among the 1-2 most highly cited investigators in the area of mycology with over 32,000 citations (Google Scholar). He is a fellow of the American College of Physicians and the Infectious Diseases Society of America. He is the recipient of many awards such as the 2004 American Society for Microbiology award for Outstanding Research in the Pathogenesis of Microbial Diseases (mentor), the America's Top Physicians in from Consumer’s Research Council of America and The University of Texas MD Anderson Cancer Center 2004 Faculty E. N Cobb Scholar Award, Faculty Achievement Award, M. D. Anderson Cancer Center, 2007, The Distinguished Clinical Faculty Mentoring Award of at MD Anderson Cancer Center, 2012, The Billy Cooper Memorial award from The Medical Mycology Society of Americas (2013), America’s Top doctors (2015), The Drouhet Medal from the European Confederation of Medical Mycology (2015), Littman award from the Mycology Society of NY (2016), emeritus member of Paul-Ehrlich-Society(2016), honorary PhD (Honoris Causa) from the National Kapodistrian University in Athens, Greece (2017). He is an American Society for Microbiology Distinguished Lecturer, 2014-2016, a fellow in American Academy of Microbiology and the president elect of Immunocompromised Host Society (2016-2018) and an inaugural lifetime fellow of the European Confederation for Medical Mycology.